Ackrell Capital Report on Cannabis Debt Financing
Summary
The document is a generic industry analysis of cannabis financing without any specific allegations, names, transactions, or controversial actions involving powerful actors. It offers no actionable inv Direct lenders are filling a financing gap for cannabis companies due to lack of bank loans. Debt costs for cannabis firms are 200‑500 basis points higher than other sectors. Valuations in the cannab
This document is from the House Oversight Committee Releases.
View Source CollectionPersons Referenced (1)
Tags
Related Documents (6)
Ackrell Capital report shows modest capital raised by U.S. publicly traded cannabis companies in 2017
The passage provides only aggregate financial data on small, largely unprofitable cannabis firms with no mention of high‑profile individuals, government agencies, or illicit activity. It lacks specifi Only $268 million total equity and debt raised by listed cannabis firms in the 12‑month period endin Most companies had little to no revenue and were not profitable. A single large $317 million finan
Ackrell Capital Cannabis Industry Segmentation Report – Concentrates Sales and Extraction Methods (Q3 2017)
The passage provides market data on cannabis concentrate sales and technical details on extraction methods. It contains no references to high‑profile individuals, government agencies, financial flows, Q3 2017 concentrate sales split: Live resin (6%), B Oils (18%), Shatter (16%), Vape oil (17%), Wax ( Two extraction categories: solvent‑based (hydrocarbon, CO₂, ethanol) and solvent‑free (filters, ic
Ackrell Capital Cannabis Investment Report (Dec 2017) outlines market size and federal‑state regulatory landscape
The passage provides general industry data and describes federal policy context but offers no concrete names, transactions, dates, or actionable leads linking high‑level officials or agencies to misco U.S. state‑legal cannabis market estimated at $8.0 billion in 2017. Breakdown by state: California $3.2 B, Colorado $1.5 B, Washington $929 M, Oregon $470 M, other stat Federal law still prohibits al
Industry benchmarking report on publicly traded CBD companies
The passage provides market sizing and retail footprint data for cannabis‑derived companies but contains no specific allegations, financial flows, or links to high‑level officials. It offers limited i Lists CEOs and executives of several CBD firms (e.g., Brian Athaide of TGOD, James Hamilton of NEPT) Notes an agreement between Organigram and 1812 Hemp for hemp research. Provides retail store count
Directory of Private Cannabis Companies Featured in House Oversight Report
The passage lists several private cannabis producers and their products without mentioning any high‑profile individuals, government agencies, financial transactions, or alleged misconduct. It offers n Level Blends – California cannabis concentrate producer. Lunchbox Alchemy – Oregon cannabis edibles and concentrates maker. LivWell Enlightened Health – Colorado/ Oregon dispensary operator and culti
Cannabis Industry Company Listings in 2017 Investment Report
The passage lists several small cannabis businesses and a research firm with no mention of high‑profile officials, financial misconduct, or controversial actions. It provides no actionable leads, date Identifies Auntie Dolores, a cannabis edibles producer in Oakland, CA. Lists BAS Research, a cannabis oil extraction and manufacturing firm in Berkeley, CA. Mentions Baker Technologies, a CRM platfor
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.